Benefits
Pregnancy nausea (NVP) — strongest evidence
meta-analysis (Nutr J 13:20) of 12 RCTs in 1,278 pregnant women showed ginger significantly improved nausea (MD 1.20, 95% CI 0.56-1.84) without significantly reducing vomiting episodes. ACOG and Society of Obstetricians and Gynaecologists of Canada include ginger as a first-line non-pharmacologic option. Subgroup analyses favor doses <1,500 mg/day.
Chemotherapy and postoperative nausea
Multiple RCTs and a 2024 umbrella review (Li et al., Int J Food Sci Nutr 75:122-133) confirm ginger reduces chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea, decreasing need for rescue antiemetics. Effect modest in magnitude but consistent. Reasonable adjunct to standard antiemetic regimens, not a replacement.
Osteoarthritis pain — modest effect
meta-analysis (Osteoarthritis Cartilage 23:13-21) of 5 placebo-controlled RCTs in 593 OA patients found ginger 'modestly efficacious' for pain and physical function. Effect size ~30% better than placebo, but ginger group was 2× as likely to discontinue. Not validated in head-to-head trials vs. NSAIDs at scale; one Wigler 2003 single trial only.
Exercise-induced muscle pain (DOMS)
RCT showed 2 g/day raw or heat-treated ginger reduced eccentric-exercise-induced arm muscle pain by 25-30%. Wilson 2018 (32 distance runners, 1.425 g/day × 5 days, downhill running protocol) showed reduced soreness and improved pain-pressure threshold. Effects most pronounced with 1-2 weeks pre-loading before unaccustomed exercise. Mechanism: COX-2 and prostaglandin E2 inhibition.
Blood sugar — mixed evidence
meta-analysis (10 RCTs, n=490) showed significant fasting glucose (-21.24 mg/dL) and HbA1c (-1.00%) reduction in T2D. However, a 2024 Clinical Nutrition ESPEN review of 5 RCTs (1.2-2 g/day, 4-12 weeks) found NO significant effect. Effect appears dose-dependent (>2 g/day in earlier positive trials). Mechanism: 6-gingerol activates PPAR-γ, inhibits alpha-glucosidase.
Anti-inflammatory and lipid effects
Multiple meta-analyses show ginger supplementation reduces CRP, IL-6, TNF-α, total cholesterol, LDL, and triglycerides — particularly in metabolic syndrome and inflammatory conditions. Effects are modest but consistent. Mechanism: dual COX-1/2 and 5-LOX inhibition (different from NSAIDs which only target COX), plus NF-κB pathway suppression and antioxidant activity.
Digestive health and motility
Ginger accelerates gastric emptying, reduces bloating, and improves GI motility — useful for functional dyspepsia, gastroparesis, and general digestive discomfort. Mechanism: 5-HT3 and 5-HT4 receptor modulation plus cholinergic enhancement. This same prokinetic activity is mechanistically linked to the anti-nausea effect (gastric stasis is a key trigger of nausea).
Dysmenorrhea (menstrual pain)
Multiple RCTs reviewed in Lete 2020 show 750-2,000 mg ginger over the first 3 days of menstruation reduces pain severity comparable to mefenamic acid and ibuprofen in young women. Mechanism: prostaglandin synthesis inhibition (same target as NSAID-class menstrual pain relief). A reasonable first-line option for those preferring botanical alternatives.
Mechanism of action
Dual COX and 5-LOX inhibition
Gingerols and shogaols inhibit cyclooxygenase-1 and -2 (COX-1/2) reducing prostaglandin synthesis, and simultaneously inhibit 5-lipoxygenase (5-LOX) reducing leukotriene production. This dual pathway inhibition provides broader anti-inflammatory coverage than NSAIDs (COX-only) or Boswellia (5-LOX-only) individually.
5-HT3 receptor antagonism for anti-nausea effects
6-gingerol and 6-shogaol antagonize 5-HT3 (serotonin type 3) receptors in the GI tract and vomiting center — the same receptor blocked by ondansetron (Zofran), a leading antiemetic drug. This mechanism produces ginger's rapid anti-nausea effects without the adverse effects of pharmaceutical 5-HT3 antagonists.
PPAR-γ activation and insulin sensitization
6-gingerol activates peroxisome proliferator-activated receptor gamma (PPAR-γ), improving adipocyte differentiation, adiponectin secretion, and peripheral insulin sensitivity. This nuclear receptor mechanism explains ginger's metabolic benefits for blood sugar control and body composition beyond its anti-inflammatory activity.
Clinical trials
12 clinical trials in 1,278 pregnant women.
1,278 pregnant women
12 clinical trials in 1,278 pregnant women. Ginger significantly improved nausea symptoms (MD 1.20, 95% CI 0.56-1.84, p=0.0002, I²=0%). Vomiting reduction trended toward significance (MD 0.72, 95% CI -0.03-1.46, p=0.06). Subgroup analyses favored daily doses <1,500 mg. Foundation for current obstetric guideline inclusion.
5 placebo-controlled clinical trials, 593 OA patients (mainly knee/hip).
593 patients across pooled studies
5 placebo-controlled clinical trials, 593 OA patients (mainly knee/hip). Ginger was 'modestly efficacious' for pain (Hedges' SMD favoring ginger) and physical function. Adverse events were mild and reversible. Authors' caveat: ginger group was 2× as likely to discontinue treatment vs. placebo group, mostly due to GI tolerability. Evidence quality judged moderate (small samples, ITT issues).
10 clinical trials, 490 T2D patients.
10 clinical trials pooled
10 clinical trials, 490 T2D patients. Significant reduction in HbA1c (WMD -1.00%, 95% CI -1.56 to -0.44, p<0.001) and fasting glucose (WMD -21.24 mg/dL, p<0.001). Note: a 2024 Clinical Nutrition ESPEN review of 5 lower-dose clinical trials (1.2-2 g/day, 4-12 weeks) found NO significant effect — suggesting effect may be dose-dependent.
32 distance runners, 1.425 g/day ginger × 5 days before downhill running protocol.
Clinical population described in trial publication.
32 distance runners, 1.425 g/day ginger × 5 days before downhill running protocol. Reduced muscle soreness and improved pain-pressure threshold post-exercise vs. placebo. Builds on (2 g/day reduced eccentric-exercise muscle pain by 25-30%). Effects strongest with 1-2 week pre-exercise loading.
10 high-quality clinical trials evaluating ginger supplementation for hyperemesis gravidarum (severe pregnancy nausea).
Clinical population described in trial publication.
10 high-quality clinical trials evaluating ginger supplementation for hyperemesis gravidarum (severe pregnancy nausea). Ginger comparable to vitamin B6 and metoclopramide for symptom relief in mild-to-moderate HG, with favorable safety profile. Severe HG generally still requires conventional antiemetic therapy.